GlobeNewswire (Wed, 10:30AM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
GlobeNewswire (May 6, 2013)
-
-
GlobeNewswire (May 2, 2013)
-
-
-
-
-
-
-
GlobeNewswire (Apr 8, 2013)
-
-
-
-
-
-
GlobeNewswire (Mar 7, 2013)
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
-
Earnings Preview: Celldex Therapeutics Reports August 10Vytautas Drumelis • Tue, Aug 7, 2012 -
-
-
-
-
Celldex's Vaccine Gets a BoostOhad Hammer • Mon, Aug 8, 2011 -
-
-
-
CellDex Therapeutics Is Back on the RadarVFC's Stock House • Wed, Oct 6, 2010
-
-
-
GlobeNewswire (Wed, 10:30AM)
-
GlobeNewswire (May 6, 2013)
-
GlobeNewswire (May 2, 2013)
-
GlobeNewswire (Apr 8, 2013)
-
GlobeNewswire (Mar 7, 2013)
-
GlobeNewswire (Feb 11, 2013)
-
GlobeNewswire (Feb 8, 2013)
-
GlobeNewswire (Feb 5, 2013)
-
GlobeNewswire (Feb 4, 2013)
-
Business Wire (Dec 11, 2012)
-
Business Wire (Dec 7, 2012)
-
Business Wire (Dec 4, 2012)
-
at CNBC.com (Nov 30, 2012)
-
Business Wire (Nov 30, 2012)
-
at CNBC.com (Nov 28, 2012)
-
Business Wire (Nov 15, 2012)
CLDX vs. ETF Alternatives
Company Description
Celldex is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex's immunotherapy platform includes a complementary portfolio of... More
